Skip to menu Skip to content Skip to footer

2004

Journal Article

Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model

Matthias, A., Blanchfield, J. T., Penman, K. G., Toth, I., Lang, C. S., De Voss, J. J. and Lehmann, R. P. (2004). Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model. Journal of Clinical Pharmacy And Therapeutics, 29 (1), 7-13. doi: 10.1046/j.1365-2710.2003.00530.x

Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model

2004

Conference Publication

Novel vaccine delivery systems

Toth, I. (2004). Novel vaccine delivery systems. GPEN 2004, Kyoto, 26-28 May, 2004.

Novel vaccine delivery systems

2004

Journal Article

Nucleophilic substitution reactions of pyranose polytosylates

McGeary, R. P., Rasoul Amini, S., Tang, V. W. S. and Toth, I. (2004). Nucleophilic substitution reactions of pyranose polytosylates. Journal of Organic Chemistry, 69 (8), 2727-2730. doi: 10.1021/jo035779k

Nucleophilic substitution reactions of pyranose polytosylates

2004

Journal Article

Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin

Ross, B. P., DeCruz, S. E., Lynch, T. B., Davis-Goff, K. and Toth, I. (2004). Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin. Journal of Medicinal Chemistry, 47 (5), 1251-1258. doi: 10.1021/jm030474j

Design, Synthesis, and Evaluation of a Liposaccharide Drug Delivery Agent: Application to the Gastrointestinal Absorption of Gentamicin

2004

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E.P. (2004). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 18th American Peptide Symposium, Boston, 19-23 July, 2004.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2004

Journal Article

Lipid core peptide technology and group A streptococcal vaccine delivery

Olive, C., Batzloff, M.R. and Toth, I. (2004). Lipid core peptide technology and group A streptococcal vaccine delivery. Expert Review of Vaccines, 3 (1), 43-58. doi: 10.1586/14760584.3.1.43

Lipid core peptide technology and group A streptococcal vaccine delivery

2004

Conference Publication

A novel liposaccharide system for the delivery of Endormorphin 1

Koda, Y., Blanchfield, J. T., Okada, Y. and Toth, I. (2004). A novel liposaccharide system for the delivery of Endormorphin 1. PSWC 2004, Kyoto, 29 May- 3 June, 2004.

A novel liposaccharide system for the delivery of Endormorphin 1

2004

Conference Publication

Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation

Liang, M.T., Davies, N. M. and Toth, I. (2004). Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation. Annual Conference of the APSA, 2004, Melbourne, Vic, Australia, 4-7 December, 2004. Mount Waverley, Victoria: Australasian Pharmaceutical Science Association.

Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation

2004

Journal Article

Mucosal immunization: Adjuvants and delivery systems

Moyle, P.M., McGeary, R. P., Blanchfield, J. T. and Toth, I. (2004). Mucosal immunization: Adjuvants and delivery systems. Current Drug Delivery, 1 (4), 385-396. doi: 10.2174/1567201043334588

Mucosal immunization: Adjuvants and delivery systems

2004

Conference Publication

Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions

Liang, M. T., Davies, N. M. and Toth, I. (2004). Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions. CTP 2004, Brisbane, 1-6 Aug 2004. Australia: Blackwell Publishing Asia.

Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions

2003

Edited Outputs

Mini-Reviews in Medicinal Chemistry

Mini-Reviews in Medicinal Chemistry. (2003). 3 (7)

Mini-Reviews in Medicinal Chemistry

2003

Journal Article

Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection

Moyle, P. M., Horvath, A., Olive, C., Good, M. F. and Toth, I. (2003). Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection. Letters In Peptide Science, 10 (5-6), 605-613. doi: 10.1007/BF02442594

Development of lipid-core-peptide (LCP) based vaccines for the prevention of the group A streptococcal (GAS) infection

2003

Journal Article

Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion

Benson, Heather A. E., Caccetta, Rima, Chen, Yan, Kearns, Philip and Toth, Istvan (2003). Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion. Letters in Peptide Science, 10 (5-6), 615-620. doi: 10.1007/BF02442595

Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion

2003

Journal Article

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens

Olive, Colleen, Batzloff, Michael, Horvath, Aniko, Clair, Timothy, Yarwood, Penny, Toth, Istvan and Good, Michael F. (2003). Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infection And Immunity, 71 (5), 2373-2383. doi: 10.1128/IAI.71.5.2373-2383.2003

Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens

2003

Journal Article

Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MII

Blanchfield, J. T., Dutton, J. T., Hogg, R. C., Gallagher, O. P., Craik, D. J., Jones, A., Adams, D. J., Lewis, R. J., Alewood, P. F. and Toth, I. (2003). Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MII. Journal of Medicinal Chemistry, 46 (7), 1266-1272. doi: 10.1021/jm020426j

Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of α-conotoxin MII

2003

Journal Article

A new principle for tight junction modulation based on occludin peptides

Tavelin, S., Hashimoto, K., Malkinson, J., Lazorova, L., Toth, I. and Artursson, P. (2003). A new principle for tight junction modulation based on occludin peptides. Molecular Pharmacology, 64 (6), 1530-1540. doi: 10.1124/mol.64.6.1530

A new principle for tight junction modulation based on occludin peptides

2003

Journal Article

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

Russell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S. and Molenaar, P. (2003). Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology - Heart & Circulatory Physiology, 285 (Oct.2003), H1576-H1581. doi: 10.1152/ajpheart.00217.2003

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure

2003

Book Chapter

Drug delivery systems utilizing lipids and sugars

Wong, A., Bender, V. and Toth, I. (2003). Drug delivery systems utilizing lipids and sugars. Molecular Pathomechanisms and New Trends in Drug Research. (pp. 599-612) edited by G. Keri and I. Toth. London & New York: Taylor & Francis. doi: 10.1201/9780203219973.ch45

Drug delivery systems utilizing lipids and sugars

2003

Conference Publication

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

Toth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 November, 2003.

Lipid and carbohydrate based macromolecules in drug and vaccine delivery

2003

Conference Publication

Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery

Marano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery. 3rd Meeting of the Australasian-Gene-Therapy-Society, Brisbane Australia, Apr 30-May 02, 2003. CHICHESTER: Wiley.

Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery